-
221
Antioxidant Activity of Bioactive Compounds in the Ethyl Acetate Extract of Putat Leaves (Planchonia valida)
Published 2022-12-01“… The Putat leaf (Planchonia valida) is a plant traditionally used by the community in the Tanjung Lanjut area, Jambi, both as a salad ingredient and as a traditional medicine to treat skin diseases and promote health. …”
Get full text
Article -
222
Isolation of Bioactive Compound in Methanolic Extract of Putat Leaves (Planchonia valida) as Antioxidant
Published 2022-12-01“… Putat leaves (Planchonia valida) are a plant that is traditionally used by people in the Tanjung Lanjut areas, Jambi as fresh vegetables, and as a traditional medicine to treat skin diseases and restore health. …”
Get full text
Article -
223
Surgical management of metastatic lesions in the proximal femur: a systematic review
Published 2025-02-01Get full text
Article -
224
Changes in cancer incidence and stage during the COVID-19 pandemic in 2020–2021 in the Nordic countries
Published 2025-02-01Get full text
Article -
225
Congenital vitamin D deficiency: presenting with feeding difficulty in early infancy: a case report
Published 2025-02-01Get full text
Article -
226
Neglected tropical diseases in Yemen: a systematic review of epidemiology and public health challenges
Published 2025-02-01Get full text
Article -
227
-
228
-
229
-
230
-
231
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Published 2024-02-01Get full text
Article -
232
Sexual and reproductive health and rights, HIV and migration in southern Africa: A rapid review
Published 2024-08-01Get full text
Article -
233
-
234
-
235
-
236
-
237
-
238
-
239
Clinical Features and Prognosis of Double-Positive Anti-MDA5 and Anti-CCP Antibodies in Dermatomyositis: A Retrospective Study
Published 2025-02-01“…Xiayu Xu,1 Longyang Zhu,2 Sizhao Li,3 Guochun Wang,3 Yongpeng Ge3 1Department of Rheumatology and Immunology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province, People’s Republic of China; 2Peking University, China-Japan Friendship School of Clinical Medicine, Beijing, People’s Republic of China; 3Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, People’s Republic of ChinaCorrespondence: Yongpeng Ge, Department of Rheumatology, The Key Laboratory of Myositis, China-Japan Friendship Hospital, Beijing, 100029, People’s Republic of China, Email [email protected]: To investigate the clinical features and prognosis of anti-melanoma differentiation-related gene 5 (MDA5) antibody and anti-cyclic citrullinated peptide (CCP) antibody double-positive dermatomyositis (DM) (MDA5+/CCP+ DM).Methods: A retrospective analysis of 264 consecutive cases of MDA5+ DM hospitalized from March 2018 to March 2022, and patients with anti-CCP antibodies were screened out. …”
Get full text
Article -
240